Titre : Inhibiteur lupique de la coagulation

Inhibiteur lupique de la coagulation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Interrupted Time Series Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteur lupique de la coagulation : Questions médicales les plus fréquentes", "headline": "Inhibiteur lupique de la coagulation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteur lupique de la coagulation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-16", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteur lupique de la coagulation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Inhibiteurs des facteurs de la coagulation sanguine", "url": "https://questionsmedicales.fr/mesh/D019774", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des facteurs de la coagulation sanguine", "code": { "@type": "MedicalCode", "code": "D019774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.113" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteur lupique de la coagulation", "alternateName": "Lupus Coagulation Inhibitor", "code": { "@type": "MedicalCode", "code": "D016682", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Schmitz", "url": "https://questionsmedicales.fr/author/Thomas%20Schmitz", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany." } }, { "@type": "Person", "name": "Charlotte A Bäuml", "url": "https://questionsmedicales.fr/author/Charlotte%20A%20B%C3%A4uml", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany." } }, { "@type": "Person", "name": "Diana Imhof", "url": "https://questionsmedicales.fr/author/Diana%20Imhof", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany. Electronic address: dimhof@uni-bonn.de." } }, { "@type": "Person", "name": "Jeremy W Jacobs", "url": "https://questionsmedicales.fr/author/Jeremy%20W%20Jacobs", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, Yale School of Medicine, 330 Cedar Street, New Haven, CT, 06520, USA. Jeremy.jacobs@yale.edu." } }, { "@type": "Person", "name": "Jiraphorn Issara-Amphorn", "url": "https://questionsmedicales.fr/author/Jiraphorn%20Issara-Amphorn", "affiliation": { "@type": "Organization", "name": "Medical Microbiology, Interdisciplinary and International Program, Graduate School, Chulalongkorn University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Influence of the Great Recession on Adolescent Major Depressive Episodes and Treatment in the United States: An Interrupted Time Series Analysis.", "datePublished": "2023-10-11", "url": "https://questionsmedicales.fr/article/37831049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jadohealth.2023.08.023" } }, { "@type": "ScholarlyArticle", "name": "The effectiveness of pay-for-performance contracts with non-governmental organizations in Afghanistan - results of a controlled interrupted time series analysis.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36750963", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09099-y" } }, { "@type": "ScholarlyArticle", "name": "The impact of systematically repairing multiple choice questions with low discrimination on assessment reliability: an interrupted time series analysis.", "datePublished": "2024-07-12", "url": "https://questionsmedicales.fr/article/39114792", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.36834/cmej.77596" } }, { "@type": "ScholarlyArticle", "name": "Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.", "datePublished": "2024-05-10", "url": "https://questionsmedicales.fr/article/38730371", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12872-024-03921-z" } }, { "@type": "ScholarlyArticle", "name": "Assessing the impact of the \"malaria supporters project\" intervention to malaria control in the Brazilian Amazon: an interrupted time-series analysis.", "datePublished": "2023-09-16", "url": "https://questionsmedicales.fr/article/37715245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12936-023-04706-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Inhibiteurs des facteurs de la coagulation sanguine", "item": "https://questionsmedicales.fr/mesh/D019774" }, { "@type": "ListItem", "position": 4, "name": "Inhibiteur lupique de la coagulation", "item": "https://questionsmedicales.fr/mesh/D016682" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteur lupique de la coagulation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteur lupique de la coagulation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteur lupique de la coagulation", "description": "Comment diagnostiquer un inhibiteur lupique de la coagulation ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les signes cliniques associés ?\nLe diagnostic nécessite-t-il des antécédents médicaux ?\nPeut-on avoir un inhibiteur sans lupus ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteur lupique de la coagulation", "description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils d'une personne à l'autre ?\nY a-t-il des symptômes spécifiques aux femmes ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?\nPeut-on avoir des symptômes sans saignement ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteur lupique de la coagulation", "description": "Peut-on prévenir l'inhibiteur lupique ?\nQuels conseils de mode de vie peuvent aider ?\nLes femmes enceintes doivent-elles être surveillées ?\nY a-t-il des vaccinations recommandées ?\nComment gérer le stress pour prévenir les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteur lupique de la coagulation", "description": "Quels traitements sont disponibles ?\nLes anticoagulants sont-ils toujours nécessaires ?\nY a-t-il des effets secondaires aux traitements ?\nLe traitement est-il à vie ?\nLes traitements sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteur lupique de la coagulation", "description": "Quelles sont les complications possibles ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?\nLes complications peuvent-elles être graves ?\nY a-t-il des signes d'alerte pour les complications ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteur lupique de la coagulation", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nY a-t-il des facteurs environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D016682?mesh_terms=Interrupted+Time+Series+Analysis&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un inhibiteur lupique de la coagulation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests de coagulation et la détection d'anticorps spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de temps de céphaline activée (TCA) et les tests d'anticorps anti-cardiolipine sont courants." } }, { "@type": "Question", "name": "Quels sont les signes cliniques associés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des saignements anormaux et des thromboses, souvent sans cause apparente." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il des antécédents médicaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents de lupus ou d'autres maladies auto-immunes sont importants." } }, { "@type": "Question", "name": "Peut-on avoir un inhibiteur sans lupus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est possible d'avoir un inhibiteur lupique sans diagnostic de lupus, bien que rare." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des saignements, des ecchymoses, et des douleurs thoraciques." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux femmes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes peuvent éprouver des symptômes liés à la grossesse, comme des complications thromboemboliques." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent s'aggraver, surtout sans traitement approprié." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans saignement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent présenter des symptômes thromboemboliques sans saignement." } }, { "@type": "Question", "name": "Peut-on prévenir l'inhibiteur lupique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé." } }, { "@type": "Question", "name": "Quels conseils de mode de vie peuvent aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être surveillées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance étroite est nécessaire pour prévenir les complications pendant la grossesse." } }, { "@type": "Question", "name": "Y a-t-il des vaccinations recommandées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations doivent être discutées avec un médecin, surtout pour les immunodéprimés." } }, { "@type": "Question", "name": "Comment gérer le stress pour prévenir les symptômes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de gestion du stress, comme la méditation, peuvent aider à réduire les symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des anticoagulants et des immunosuppresseurs pour gérer les symptômes." } }, { "@type": "Question", "name": "Les anticoagulants sont-ils toujours nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, leur nécessité dépend de la gravité des symptômes et des antécédents médicaux." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent avoir des effets secondaires, comme des saignements ou des infections." } }, { "@type": "Question", "name": "Le traitement est-il à vie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la réponse au traitement et de l'évolution de la maladie, souvent à long terme." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des traitements sont efficaces pour contrôler les symptômes et prévenir les complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des thromboses, des AVC et des problèmes cardiaques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent survenir, mais leur fréquence dépend de la gestion de la maladie." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement approprié et un suivi régulier peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être graves et nécessiter une intervention médicale urgente." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte pour les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques ou des troubles neurologiques doivent alerter immédiatement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le sexe féminin, des antécédents familiaux et d'autres maladies auto-immunes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque est plus élevé chez les jeunes femmes, généralement entre 15 et 45 ans." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies auto-immunes augmentent le risque d'inhibiteur lupique." } }, { "@type": "Question", "name": "Le stress peut-il être un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains médicaments ou à des agents environnementaux peut être un facteur." } } ] } ] }

Sources (10000 au total)

The Influence of the Great Recession on Adolescent Major Depressive Episodes and Treatment in the United States: An Interrupted Time Series Analysis.

In the United States, adolescent depression increased beginning in 2008-2010, coinciding with the Great Recession. We investigated whether this time of changing economic circumstances impacted adolesc... We analyzed data for adolescents aged 12-17 years from the 2004-2019 National Survey on Drug Use and Health (N = 256,572). Adolescents' past-year major depressive episodes (MDEs) were measured by self... The Great Recession was not associated with an immediate increase in MDE prevalence (β:-0.77 [i.e., quarter-year change in prevalence], 95% confidence interval (CI): -2.23, 0.69). However, the increas... The Great Recession was not associated with increased adolescent depression prevalence, although there was an acceleration in the trend of adolescent MDE following the recession. The prevalence of MDE...

The effectiveness of pay-for-performance contracts with non-governmental organizations in Afghanistan - results of a controlled interrupted time series analysis.

In many contexts, including fragile settings like Afghanistan, the coverage of basic health services is low. To address these challenges there has been considerable interest in working with NGOs and e... We conducted an interrupted time series (ITS) analysis with a non-randomized comparison group that employed segmented regression models and used independently verified health management information sy... Independent verification of the HMIS data found that consistency and accuracy was greater than 90% in the contracted provinces. The introduction of P4P increased the 10 P4P-compensated service deliver... P4P contracts with NGOs led to a substantial improvement in service delivery at lower cost despite a very difficult security situation. The promising results from this large-scale experience warrant m...

The impact of systematically repairing multiple choice questions with low discrimination on assessment reliability: an interrupted time series analysis.

At our centre, we introduced a continuous quality improvement (CQI) initiative during academic year 2018-19 targeting for repair multiple choice question (MCQ) items with discrimination index (...

Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.

The 2013 ACC/AHA Guideline was a paradigm shift in lipid management and identified the four statin-benefit groups. Many have studied the guideline's potential impact, but few have investigated its pot... To evaluate the potential (long-term) impact of the 2013 ACC/AHA Guideline release in Nov 2013 in the U.S., we investigated the association of the 2013 ACC/AHA Guideline with the trend changes in 5-Ye... 197,021 patients were included (ASCVD: 19,060; High-LDL: 33,907; Diabetes: 138,159; High-ASCVD-Risk: 5,895). After the guideline release, the long-term trend (slope) of 5-Year MACE Survival for the Di... The 2013 ACA/AHA Guideline release is associated with trend improvements in the long-term MACE Survival for Diabetes group and optimal statin use for ASCVD group. These significant associations might ...

Assessing the impact of the "malaria supporters project" intervention to malaria control in the Brazilian Amazon: an interrupted time-series analysis.

In 2021, Brazil was responsible for more than 25% of malaria cases in the Americas. Although the country has shown a reduction of cases in the last decades, in 2021 it reported over 139,000 malaria ca... An ecological time-series analysis was conducted to assess the "Malaria Supporters Project" effect. The study used data on Annual Parasitic Incidence (API) spanning the period from 2003 to 2020 across... The intervention group registered 1,104,430 cases between 2012 and 2020, a 50.6% reduction compared to total cases between 2003 and 2011. In 2020 there were 95,621 cases, 50.4% fewer than in 2011. The... The intervention is not a silver bullet to control malaria, but it has reduced API in locations with high malaria endemicity. Furthermore, the model has the potential to be replicated in other countri...

Evaluating the effect of the COVID-19 pandemic on hypertension and diabetes care in South Korea: an interrupted time series analysis.

Access to healthcare services is important, especially for patients with chronic diseases. We evaluated the effect of the COVID-19 pandemic on outpatient visits and medication for patients with hypert... Nationwide claims data were extracted for patients with hypertension and diabetes from January 2019 to July 2020. We used an interrupted time series (ITS) analysis to evaluate the pandemic's impact on... The number of outpatient visits for diabetes significantly declined in February 2020, when community transmission began. However, when high-intensity social distancing was relaxed in April 2020, outpa... Outpatient visits decreased immediately when COVID-19 spread to local communities. However, the number of days of medication supplied per visit increased to compensate for the longer intervals between...

The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis.

The overload of health services because of the COVID-19 pandemic has reduced the population's access to treatment and prevention of other diseases. This study aimed to identify whether there was a cha... This was an ecological time series study of mammograms and breast biopsies in women aged 30 years or older from an open-access data set of the Public Health System of Brazil from 2017 to July 2021.... In 2020, there was a reduction of -40.9% in mammograms and -7.9% in breast biopsies compared with the prepandemic period. From 2017 to 2020, there was an increase in the breast biopsies ratio per mamm... The COVID-19 pandemic harmed the increasing trend of breast biopsies, their total direct costs, BI-RADS 0 to III and IV to V mammograms, observed in the prepandemic period. Furthermore, there was a te...

Interrupted time series analysis of chronic periodontitis-related procedures before and after the scaling reimbursement policy in Korea.

To study the use of a quasi-experimental design to assess the effects of scaling reimbursement policies on the incidence of chronic-periodontitis procedures.... Interrupted time series analysis was used to compare the effects before and after policy implementation using data on the number of periodontitis-related procedures from the Korean National Health Ins... Following the policy implementation from July 2013, an immediate increase was observed in total and basic procedures. No significant changes were noted in intermediate and advanced procedures initiall... Following the new policy implementation, the number of intermediate procedures decreased while the number of advanced procedures increased, especially among patients with comorbidities. These findings...

Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis.

Prescription opioids were a major initial driver of the opioid crisis. States have attempted to reduce overprescribing by enacting policies that limit opioid prescriptions, but the impacts of such pol... To examine the association of implementation of a state prescribing limits policy with opioid prescribing and transitions to long-term opioid use.... Interrupted time series analyses assessing trends in new opioid prescriptions and long-term use before and after policy implementation.... A total of 130,591 New Jersey Medicaid enrollees ages 18-64 who received an initial opioid prescription from January 2014 to December 2019.... New Jersey's opioid prescribing limit policy implemented in March 2017.... Total new opioid prescriptions, percentage of new prescriptions with >5 days' supply, and transition to long-term opioid use, defined as having opioid supply on day 90 after the initial prescription.... Policy implementation was associated with a significant monthly increase in new opioid prescriptions of 0.86 per 10,000 enrollees, halving the pre-policy decline in the prescribing rate. Among new opi... The New Jersey policy was associated with a reduction in initial prescriptions with >5 days' supply, but not with an overall decline in new opioid prescriptions or in the rate at which initial prescri...

Emergency department presentations during the COVID-19 pandemic in Queensland (to June 2021): interrupted time series analysis.

To assess emergency department (ED) presentation numbers in Queensland during the coronavirus disease 2019 (COVID-19) pandemic to mid-2021, a period of relatively low COVID-19 case numbers.... Interrupted time series analysis.... All 105 Queensland public hospital EDs.... Numbers of ED presentations during the COVID-19 lockdown period (11 March 2020 - 30 June 2020) and the period of easing restrictions (1 July 2020 - 30 June 2021), compared with pre-pandemic period (1 ... During the lockdown period, the mean number of ED presentations was 19.4% lower (95% confidence interval, -20.9% to -17.9%) than during the pre-pandemic period (predicted mean number: 5935; actual num... The COVID-19 pandemic and related public restrictions were associated with profound changes in health care use. Pandemic plans should include advice about continuing to seek care for serious health co...